110 related articles for article (PubMed ID: 9308954)
1. Tumor type and vascularity: important variables in infusional brachytherapy with colloidal 32P.
Nguyen H; Ghanem G; Morandini R; Verbist A; Larsimont D; Fallais C; Frühling J; Van Houtte P
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):481-7. PubMed ID: 9308954
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cellular uptake, tumor retention, radiation response, and tumor pathophysiology in experimental solid tumors after an intratumoral infusion of colloidal 32P.
Lee I; Wallner PE
Cancer; 1997 Dec; 80(12 Suppl):2611-7. PubMed ID: 9406715
[TBL] [Abstract][Full Text] [Related]
3. The effect of various therapeutic solutions including colloidal chromic 32P via an intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice.
Lee I; Lee YH
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3139s-3142s. PubMed ID: 10541354
[TBL] [Abstract][Full Text] [Related]
4. A new method for delivering radioactive cytotoxic agents in solid cancers.
Order SE; Siegel JA; Lustig RA; Principato R; Zeiger LS; Johnson E; Zhang H; Lang P; Pilchik NB; Metz J
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):715-20. PubMed ID: 7928505
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tumor targeting by an intratumoral injection of colloidal chromic 32P in two human tumors (AsPC-1 pancreas and Ls174T colon) in nude mice.
Lee I
J Surg Oncol; 1999 Mar; 70(3):161-6. PubMed ID: 10102345
[TBL] [Abstract][Full Text] [Related]
6. Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study.
Order SE; Siegel JA; Principato R; Zeiger LE; Johnson E; Lang P; Lustig R; Wallner PE
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1117-26. PubMed ID: 8985034
[TBL] [Abstract][Full Text] [Related]
7. Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice.
Zhang K; Loong SL; Connor S; Yu SW; Tan SY; Ng RT; Lee KM; Canham L; Chow PK
Clin Cancer Res; 2005 Oct; 11(20):7532-7. PubMed ID: 16243828
[TBL] [Abstract][Full Text] [Related]
8. Complete remission of nonresectable pancreatic cancer after infusional colloidal phosphorus-32 brachytherapy, external beam radiation therapy, and 5-fluorouracil: a preliminary report.
DeNittis AS; Stambaugh MD; Lang P; Wallner PE; Lustig RA; Dillman RO; Order SE
Am J Clin Oncol; 1999 Aug; 22(4):355-60. PubMed ID: 10440189
[TBL] [Abstract][Full Text] [Related]
9. [Intratumoral injection of macroaggragated albumin and colloidal 32P for the treatment of hepatocellular carcinoma].
Liu J; Yang C; Shao W; Han J
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):309-11. PubMed ID: 11676882
[TBL] [Abstract][Full Text] [Related]
10. Preliminary experience of infusional brachytherapy using colloidal 32P.
Order SE; Siegel JA; Principato R; Zeiger LS; Johnson E; Lang P; Lustig R; Kroprowski C; Wallner PE
Ann Acad Med Singap; 1996 May; 25(3):347-51. PubMed ID: 8876899
[TBL] [Abstract][Full Text] [Related]
11. Bioevaluation studies of 32P incorporated mould brachytherapy sources for potential application in treatment of superficial tumors.
Pandey U; Saxena SK; Sarma HD; Tandon P; Ram R; Samuel G; Dash A; Venkatesh M
Nucl Med Commun; 2008 Aug; 29(8):717-23. PubMed ID: 18753825
[TBL] [Abstract][Full Text] [Related]
12. Chromic-P32 phosphate treatment of implanted pancreatic carcinoma: mechanism involved.
Liu L; Feng GS; Gao H; Tong GS; Wang Y; Gao W; Huang Y; Li C
World J Gastroenterol; 2005 Apr; 11(14):2101-8. PubMed ID: 15810075
[TBL] [Abstract][Full Text] [Related]
13. Use of colloids of chromic [32P] phosphate in treatment of solid tumors.
Zubillaga MB; Boccio JR; Nicolini JO; Ughetti R; Lanari E; Caro RA
Nucl Med Biol; 1996 Oct; 23(7):907-10. PubMed ID: 8971858
[TBL] [Abstract][Full Text] [Related]
14. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
15. Objective responses after fractionated infusional brachytherapy of unresectable pancreatic adenocarcinomas.
Westlin JE; Andersson-Forsman C; Garske U; Linné T; Aas M; Glimelius B; Lindgren PG; Order SE; Nilsson S
Cancer; 1997 Dec; 80(12 Suppl):2743-8. PubMed ID: 9406733
[TBL] [Abstract][Full Text] [Related]
16. Bioevaluation of 32P patch designed for the treatment of skin diseases.
Salgueiro MJ; Duran H; Palmieri M; Pirchio R; Medina V; Ughetti R; Croci M; Nicolini J; Zubillaga M
Nucl Med Biol; 2008 Feb; 35(2):233-7. PubMed ID: 18312834
[TBL] [Abstract][Full Text] [Related]
17. [Implantation brachytherapy with 32P-chromic phosphate-poly (L-lactide) delayed-release particles for prostate cancer in nude mice].
He XJ; Jia RP; Shao GQ; Xu LW; Wang ZZ; Huang PL; Wu JP; Wang J
Zhonghua Nan Ke Xue; 2010 Oct; 16(10):872-6. PubMed ID: 21243748
[TBL] [Abstract][Full Text] [Related]
18. Clinical fusion of three-dimensional images using Bremsstrahlung SPECT and CT.
Parsai EI; Ayyangar KM; Dobelbower RR; Siegel JA
J Nucl Med; 1997 Feb; 38(2):319-24. PubMed ID: 9025762
[TBL] [Abstract][Full Text] [Related]
19. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
[TBL] [Abstract][Full Text] [Related]
20. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
